middle.news
How InhaleRx’s Expanded IRX-211 Trial Could Fast-Track Market Entry
3:11pm on Tuesday 3rd of June, 2025 AEST
•
Healthcare
Read Story
How InhaleRx’s Expanded IRX-211 Trial Could Fast-Track Market Entry
3:11pm on Tuesday 3rd of June, 2025 AEST
Key Points
Rapid HREC approval granted without queries
Trial participant target increased from 60 to 156
Potential to eliminate Phase 3 trial phase
Manufacturing secured with first Clendon Capital drawdown
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Inhalerx (ASX:IRX)
OPEN ARTICLE